59563
SUPELCOSIL™ LC-8-DB (5 µm) HPLC Columns
L × I.D. 2 cm × 4 mm Supelguard Guard Cartridge pkg of 2 ea, Guard Cartridge holder required for use
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
Acerca de este artículo
UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
NB.21
L × i.d.:
2 cm × 4 mm
Particle size:
5 μm
Matrix active group:
C8 (RP8), C8 (octyl) phase
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleNombre del producto
Cartucho SUPELCOSIL™ LC-8-DB Supelguard, 5 μm particle size, L × I.D. 2 cm × 4 mm
agency
suitable for USP L7
Quality Level
packaging
pkg of 2 ea
technique(s)
HPLC: suitable
L × I.D.
2 cm × 4 mm
matrix active group
C8 (RP8), C8 (octyl) phase
particle size
5 μm
application(s)
food and beverages
separation technique
reversed phase
Still not finding the right product?
Explore all of our products under Cartucho SUPELCOSIL™ LC-8-DB Supelguard
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Vesna Cerkvenik-Flajs et al.
Analytica chimica acta, 663(2), 165-171 (2010-03-09)
An analytical method has been developed for the simultaneous determination of the following endectocide drugs in milk: ivermectin, abamectin, doramectin, moxidectin, eprinomectin, emamectin and nemadectin. Samples were extracted with acetonitrile, purified with solid-phase extraction on a reversed phase C(8), derivatised
J H Nichols et al.
Clinical chemistry, 40(7 Pt 1), 1312-1316 (1994-07-01)
This automated assay determines the concentration of the antidepressant fluoxetine (Prozac) and its active metabolite norfluoxetine in serum by reversed-phase HPLC with spectrophotometric detection. Extraction, injection, and quantification are performed by the Gilson Aspec automated sample handler. The patient's specimen
Jadwiga Piwowarska et al.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 805(1), 1-5 (2004-04-29)
A high-performance liquid chromatographic method is described for determination of lidocaine (2-(dietyloamino)-N-(2,6-dimetylofenylo) acetamid) and its metabolite, monoethylglycine xylidide (MEGX), in human serum containing various concentration of bilirubin. Lidocaine and its metabolite were extracted from human serum using dichloromethane. After separation